Clera Inc - Company Review
SummaryClera Inc - Company Review
Summary
Clera Inc (Clera) is a drug discovery and development company that discovers and develops drugs for age related diseases. The company offers drugs for diseases such as Parkinson’s disease, cognition, alzheimer’s and the psychosis related to dementia, schizophrenia and Parkinson’s disease. It develops treatment to improve the efficacy of anti-Parkinson’s disease cure. Clera’s CLR4001 has mechanism of action for diminishing the scope and symptoms of Parkinson's without tolerance or dyskinesia developing. The company’s CLR3001 is a Phase II compound, which repurposes and reformulate generic compound for different central nervous system disorders. It operates through its offices in Toronto and Vancouver, Canada. Clera is headquartered in Vancouver, British Columbia, Canada.
This comprehensive company report of Clera Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.